Concepedia

Multiple-dose Relative Bioavailability

Multiple-Dose Relative Bioavailability is the ratio of the systemic exposure of a drug achieved at steady state following multiple administrations of a test formulation to that of a reference formulation, expressed as the area under the concentration-time curve over one dosing interval, serving as a measure of the equivalence in extent of absorption between two formulations under repeated dosing conditions.

27

Publications

869

Citations

148

Authors

58

Institutions

Publications per year

2017–2026

9

Parents

Publications

27

Pharmacokinetics of Tedizolid Following Oral Administration: Single and Multiple Dose, Effect of Food, and Comparison of Two Solid Forms of the Prodrug

Shawn D. Flanagan, Paul Bien, Kelly A. Muñoz et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2013 · 96 citations · Full text

, , +17

Intramuscular and oral disposition of enrofloxacin in African grey parrots following single and multiple doses

Keven Flammer, David P. AuCoin, D. A. Whitt · Journal of Veterinary Pharmacology and Therapeutics · 1991 · 62 citations

, , +13

First‐in‐human safety, tolerability, and pharmacokinetic results of DFV890, an oral low‐molecular‐weight NLRP3 inhibitor

Ewa Gatlik, Beata Mehes, Emilie Voltz et al. · Clinical and Translational Science · 2024 · 52 citations · Full text

, , +13

Pharmacokinetic and Pharmacodynamic Characteristics and Safety of Inhaled Albuterol Enantiomers in Healthy Volunteers

Kavita Gumbhir‐Shah, Donald J. Kellerman, Sidney S. DeGraw et al. · The Journal of Clinical Pharmacology · 1998 · 51 citations

, , +15

Relative bioavailability and pharmacokinetics of two oral formulations of docosahexaenoic acid/eicosapentaenoic acid after multiple-dose administration in healthy volunteers

Antonio Rusca, Andrea F. D. Di Stefano, Mira Doig et al. · European Journal of Clinical Pharmacology · 2009 · 50 citations

, , +17

1–5 of 27

Authors

148

  1. DJ
    David J. Greenblatt

    Tufts University, United States

    2 publications · 75 citations

    2

    h-index

  2. RI
    Richard I. Shader

    Tufts University, United States

    2 publications · 75 citations

    2

    h-index

  3. PK
    Patrick Koch

    Saarland University, Germany

    1 publications · 51 citations

    1

    h-index

  4. LD
    Larry D. Craig

    National Jewish Health, United States

    1 publications · 12 citations

    1

    h-index

  5. RR
    Robert Risinger

    Medical College of Wisconsin, United States

    1 publications · 42 citations

    1

    h-index

1–5 of 148

Institutions

58

  1. Alkermes (United States)

    Waltham, United States

    1 h-index

    5 publications

    210 citations

  2. University at Buffalo, State University of New York

    Buffalo, United States

    1 h-index

    2 publications

    102 citations

  3. Boston Collaborative Drug Surveillance Program

    Lexington, United States

    1 h-index

    1 publications

    42 citations

  4. University of Pavia

    Pavia, Italy

    1 h-index

    1 publications

    50 citations

  5. Novo Nordisk (Denmark)

    Copenhagen, Denmark

    1 h-index

    1 publications

    37 citations

  6. Roswell Park Comprehensive Cancer Center

    Buffalo, United States

    1 h-index

    4 publications

    120 citations

  7. Albany Medical Center Hospital

    Albany, United States

    1 h-index

    1 publications

    20 citations

  8. Novartis (Switzerland)

    Basel, Switzerland

    1 h-index

    7 publications

    364 citations

1–8 of 58

Venues

  1. PubMed

    Repository · 3 publications · 65 citations

    3

    h-index

  2. The Journal of Clinical Pharmacology

    3 publications · 105 citations

    3

    h-index

  3. Clinical Therapeutics

    2 publications · 35 citations

    2

    h-index

  4. 2

    h-index

  5. 1

    h-index

1–5